OTCMKTS:MMNFF MedMen Enterprises (MMNFF) Stock Price, News & Analysis → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free MMNFF Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range$0.00▼$0.0252-Week Range N/AVolume5,001 shsAverage Volume705,413 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Get MedMen Enterprises alerts: Email Address Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. About MedMen Enterprises Stock (OTCMKTS:MMNFF)MedMen Enterprises Inc., together with its subsidiaries, operates as a cannabis retailer in the United States. The company provides products under the MedMen Red and LuxLyte brand names. As of June 25, 2022, it operated 19 stores in California, Nevada, Illinois, Arizona, and Massachusetts. MedMen Enterprises Inc. is based in Los Angeles, California.Read More Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. MMNFF Stock News HeadlinesApril 26, 2024 | businesswire.comMedMen Announces Entering Bankruptcy Proceedings and Resignation of CFO and DirectorsJanuary 25, 2024 | msn.comMedMen Appoints Expert Richard Ormond as Chief Restructuring OfficerApril 27, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.January 25, 2024 | msn.comMedMen Enterprises Announces Regulation FD DisclosureJanuary 24, 2024 | msn.comMedMen goes from height of $3B valuation to zero as stock draws cease-trade orderJanuary 5, 2024 | financialpost.comMedMen Exits Arizona Market, Completing Sale of Local Operations to MINT CannabisDecember 20, 2023 | msn.comMedMen Sells Arizona And Nevada Cannabis Assets: CEO Explains What's NextDecember 20, 2023 | finance.yahoo.comMedMen Enters into Definitive Agreements to Exit Arizona and Nevada per Announced Strategic Review, Selling Non-Core Assets to MINT CannabisApril 27, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.December 7, 2023 | morningstar.comMedMen Enterprises Inc MMNFFNovember 16, 2023 | finance.yahoo.comMedMen Provides Annual Filing Status ReportNovember 2, 2023 | finance.yahoo.comMedMen Announces Delay of Filing of Financial Statements for the Year Ended July 1, 2023 and Issuance of Management Cease Trade OrderJuly 6, 2023 | msn.comMedMen Appoints Ellen Deutsch As CEO And Amit Pandey As CFOJune 18, 2023 | marketwatch.comMedMen Enterprises CFO ResignsMay 28, 2023 | forbes.comZee Entertainment EnterprisesMay 17, 2023 | finance.yahoo.comMedMen Expands Chicago-Area Footprint, Opens Newest Dispensary in Morton GroveMarch 23, 2023 | finance.yahoo.comMedMen Enterprises Announces Change of AuditorMarch 21, 2023 | msn.comPassage of cannabis banking bill needs lobbying push - GOP SenatorMarch 8, 2023 | finance.yahoo.comNational Survey Reveals More Than One-Third of U.S. Women Consume Cannabis, But Stigmas LingerJanuary 27, 2023 | reuters.comMaybank, ADIA snap up shares in Adani's secondary share offeringJanuary 17, 2023 | uk.finance.yahoo.comMedMen Enterprises Inc. (0JS.SG)November 21, 2022 | finance.yahoo.comNew York Grants First 37 Licenses for Weed DispensariesSeptember 16, 2022 | seekingalpha.comMMNFF MedMen Enterprises Inc.August 26, 2022 | msn.comGreen Sentry Acquires MedMen's Florida Medical Marijuana Treatment Center License And AssetsAugust 24, 2022 | morningstar.comMedMen Completes Sale of Florida Assets | MorningstarAugust 22, 2022 | financialpost.comMedMen Completes Sale of Florida AssetsAugust 6, 2022 | businessinsider.comA 24-year-old stock trader made over $8 million in 2 years. Here's how he identifies a winning trade regardless of stock-market conditions.See More Headlines Receive MMNFF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MedMen Enterprises and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/15/2021Today4/26/2024Next Earnings (Estimated)5/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:MMNFF CUSIPN/A CIK1776932 Webwww.medmen.com Phone(855) 292-8399FaxN/AEmployees428Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Amit Pandey (Age 42)Chief Financial Officer Ms. Melony Valleau CPA (Age 55)Chief Accounting Officer Ms. Stéphanie Van HasselVice President of Investor RelationsKimble CannonGeneral Counsel & Corporate SecretaryKaren TorresChief Supply Chain OfficerRichard OrmondChief Restructuring OfficerMore ExecutivesKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors MMNFF Stock Analysis - Frequently Asked Questions When is MedMen Enterprises' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 23rd 2024. View our MMNFF earnings forecast. How were MedMen Enterprises' earnings last quarter? MedMen Enterprises Inc. (OTCMKTS:MMNFF) posted its earnings results on Monday, February, 15th. The company reported ($0.11) earnings per share for the quarter, missing the consensus estimate of ($0.08) by $0.03. Read the conference call transcript. How do I buy shares of MedMen Enterprises? Shares of MMNFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:MMNFF) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MedMen Enterprises Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.